SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹122 Cr | ₹117 Cr | ₹85 Cr | ₹57 Cr | ₹58 Cr |
What is the latest Total Liabilities ratio of SAMRAT PHARMACHEM ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹122 Cr |
Mar2023 | ₹117 Cr |
Mar2022 | ₹85 Cr |
Mar2021 | ₹57 Cr |
Mar2020 | ₹58 Cr |
How is Total Liabilities of SAMRAT PHARMACHEM Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹122 Cr | 4.41 | |
Mar2023 | ₹117 Cr | 37.79 | |
Mar2022 | ₹85 Cr | 47.42 | |
Mar2021 | ₹57 Cr | -1.63 | |
Mar2020 | ₹58 Cr | - |
Compare Total Liabilities of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹99.0 Cr | -6.2% | -13% | -16.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,195.0 Cr | 0.3% | -4% | -6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,417.0 Cr | 2% | -9.6% | 33.1% | Stock Analytics | |
CIPLA | ₹124,867.0 Cr | 1.9% | 4.5% | -0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,971.0 Cr | 0.6% | 3.6% | 9.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,956.0 Cr | 2% | -1% | -7% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -6.2% |
-13% |
-16.5% |
SENSEX | 2% |
0.1% |
1.8% |
You may also like the below Video Courses